ArticleJournal of hematology & oncology2022

Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy.

Peiting Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.